Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

63.09 +0.86 (+1.37%)
Streaming Delayed Price Updated: 11:12 AM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,628,723
Open 63.40
Bid (Size) 63.08 (200)
Ask (Size) 63.09 (900)
Prev. Close 62.23
Today's Range 63.00 - 64.16
52wk Range 43.08 - 93.80
Shares Outstanding N/A
Dividend Yield 1.85%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Viking Therapeutics (VKTX) 2026 Deep Dive: Challenging the Obesity Duopoly
Date: January 23, 2026 Introduction In the high-stakes arena of metabolic medicine, few companies have generated as much speculative fervor and clinical awe as Viking Therapeutics (NASDAQ: VKTX). As of... 
Via Finterra
Topics Intellectual Property
News headline image
Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 ↗
This biotech has candidates in late-stage clinical development. 
Via The Motley Fool

Performance

YTD
+20.4%
+20.4%
1 Month
+22.2%
+22.2%
3 Month
+18.5%
+18.5%
6 Month
-10.8%
-10.8%
1 Year
-21.7%
-21.7%

More News

Read More
News headline image
The Trillion-Dollar Heavyweight: Eli Lilly Surge Signals Unrivaled Dominance in the GLP-1 Era
Via MarketMinute
Topics Economy
Novo Nordisk A/S-Spons ADR (NYSE:NVO) Demonstrates a Strong Dividend Profile Backed by High Profitability ↗
Via Chartmill
NVO Shares Rise On Strong Kickstart For Wegovy Pill In US: Retail Eyes Up To $110 As ‘Fair Value’ ↗
Via Stocktwits
News headline image
VIX Tumbles as Trump Rescinds Greenland Tariff Threats
Via MarketMinute
Topics Bonds Government Stocks
News headline image
Arctic Ultimatum: Trump’s Greenland Tariff Threat Triggers $4,700 Gold Surge and 870-Point Dow Plunge
Via MarketMinute
Topics Economy Government Stocks
News headline image
2 Top Stocks to Double Up On Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Novo Nordisk Inks Deal With Canada’s Aspect Biosystems To Find More Diabetes Meds Besides Ozempic ↗
Via Stocktwits
News headline image
What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026? ↗
Via The Motley Fool
News headline image
Is Oral Wegovy a Game Changer for Novo Nordisk? ↗
Via The Motley Fool
News headline image
Arctic Chill: Global Markets Reeling as Trump Demands Greenland Purchase with Massive Tariff Threats
Via MarketMinute
Topics Economy Government Stocks
News headline image
The Arctic Gambit: Trump’s National Security Push for Greenland Sparks Diplomatic Crisis and Market Volatility
Via MarketMinute
Topics Economy Electric Vehicles Government
News headline image
The Battle for the White Coat: OpenAI and Anthropic Reveal Dueling Healthcare Strategies
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All ↗
Via MarketBeat
Topics ETFs
News headline image
Anthropic’s New Specialized Healthcare Tiers: A New Era for AI-Driven Diagnostics and Medical Triage
Via TokenRing AI
Topics Artificial Intelligence
News headline image
The Trillion-Dollar Pharmacopeia: Eli Lilly’s (LLY) Dominance in the Age of Incretins
Via Finterra
Topics Economy
News headline image
The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature
Via Finterra
Topics Artificial Intelligence Bankruptcy Economy
News headline image
Prediction: 2026 Will Be the Year of Eli Lilly ↗
Via The Motley Fool
News headline image
The Arctic Ultimatums: Trump’s Greenland Bid Sparks Global Trade War and NATO Crisis
Via MarketMinute
Topics Economy Government World Trade
News headline image
Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? ↗
Via The Motley Fool
News headline image
NVO Stock Is Rising Pre-Market – What Is The Wegovy News Driving Novo Nordisk Shares? ↗
Via Stocktwits
News headline image
Novo Nordisk Stock Dips As Company Faces GLP-1 Antitrust Lawsuit ↗
Via Benzinga
Topics Lawsuit
News headline image
Eli Lilly’s $1.2 Billion Acquisition of Ventyx Biosciences: Bridging the Gap Between Weight Loss and Chronic Inflammation
Via MarketMinute
Topics Intellectual Property
News headline image
Eli Lilly Stock Slips After Antitrust Lawsuit Against GLP-1 Providers ↗
Via Benzinga
Topics Lawsuit

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 63.09
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 01/23/26 11:12 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.